Atlas Trials

A Study to Assess the Safety of a New Inserter Device for Paragard® (Intrauterine Copper Contraceptive)

Clinical trial NCT05309694 · COMPLETED

Trial details

NCT number
NCT05309694
Sponsor
CooperSurgical Inc.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Contraception
Start date
2022-03-04
Primary completion
2022-12-08
Enrollment
119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.